BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12417512)

  • 1. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study.
    Roviello F; Marrelli D; Morgagni P; de Manzoni G; Di Leo A; Vindigni C; Saragoni L; Tomezzoli A; Kurihara H;
    Ann Surg Oncol; 2002 Nov; 9(9):894-900. PubMed ID: 12417512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benefits of extended lymphadenectomy in patients with gastric carcinoma with metastasis to second level lymph nodes. An Italian multicenter study].
    Roviello F; Marrelli D; Morgagni P; De Manzoni G; Di Leo A; Vindigni C; Nastri G; Saragoni L; Tomezzoli A; Kurihara H; De Stefano A
    Chir Ital; 2003; 55(4):491-8. PubMed ID: 12938593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
    Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
    Volpe CM; Driscoll DL; Douglass HO
    Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
    Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
    Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
    Yildirim E; Celen O; Berberoglu U
    J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphadenectomy in patients with gastric cancer. A critical review.
    Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M
    Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
    Galizia G; Lieto E; De Vita F; Castellano P; Ferraraccio F; Zamboli A; Mabilia A; Auricchio A; De Sena G; De Stefano L; Cardella F; Barbarisi A; Orditura M
    Surgery; 2015 Feb; 157(2):285-96. PubMed ID: 25532433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
    Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
    Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefit of extended D2 resection for proximal gastric cancer.
    Volpe CM; Driscoll DL; Miloro SM; Douglass HO
    J Surg Oncol; 1997 Mar; 64(3):231-6. PubMed ID: 9121155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
    Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
    Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of the histologically and immunohistochemically detected solitary lymph node metastases in gastric cancer.
    Griniatsos J; Yiannakopoulou E; Gakiopoulou H; Alexandrou A; Dimitriou N; Karavokyros I; Felekouras E
    Scand J Surg; 2011; 100(3):174-80. PubMed ID: 22108745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
    Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study.
    Pacelli F; Cusumano G; Rosa F; Marrelli D; Dicosmo M; Cipollari C; Marchet A; Scaringi S; Rausei S; di Leo A; Roviello F; de Manzoni G; Nitti D; Tonelli F; Doglietto GB;
    JAMA Surg; 2013 Apr; 148(4):353-60. PubMed ID: 23715879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.